Minjun Du

412 total citations
18 papers, 313 citations indexed

About

Minjun Du is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minjun Du has authored 18 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minjun Du's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (4 papers). Minjun Du is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (6 papers) and Epigenetics and DNA Methylation (4 papers). Minjun Du collaborates with scholars based in China and United States. Minjun Du's co-authors include Yushun Gao, Yanjiao Zhang, Qi Xue, Dali Wang, Jun Zhao, Jinfeng Huang, Yousheng Mao, Shugeng Gao, Shugeng Gao and Qi Xue and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Minjun Du

15 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minjun Du China 8 275 218 32 31 25 18 313
Pingting Ying China 10 275 1.0× 128 0.6× 32 1.0× 27 0.9× 45 1.8× 17 321
Yi Miao China 5 218 0.8× 162 0.7× 22 0.7× 15 0.5× 29 1.2× 6 260
Zhi‐Man Zhu China 9 322 1.2× 178 0.8× 27 0.8× 13 0.4× 48 1.9× 14 338
Senxu Lu China 9 401 1.5× 316 1.4× 19 0.6× 37 1.2× 48 1.9× 9 460
Lingxing Zeng China 7 292 1.1× 183 0.8× 17 0.5× 26 0.8× 61 2.4× 8 341
Lisha Zhuang China 7 287 1.0× 181 0.8× 18 0.6× 23 0.7× 63 2.5× 8 336
Naichun Zhou China 6 239 0.9× 174 0.8× 23 0.7× 33 1.1× 27 1.1× 7 290
Chengzhou Lv China 9 213 0.8× 147 0.7× 12 0.4× 26 0.8× 30 1.2× 18 304
Bingrui Yan China 6 269 1.0× 182 0.8× 29 0.9× 22 0.7× 26 1.0× 8 290
Junge Deng China 7 345 1.3× 261 1.2× 13 0.4× 23 0.7× 47 1.9× 12 393

Countries citing papers authored by Minjun Du

Since Specialization
Citations

This map shows the geographic impact of Minjun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjun Du more than expected).

Fields of papers citing papers by Minjun Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjun Du. The network helps show where Minjun Du may publish in the future.

Co-authorship network of co-authors of Minjun Du

This figure shows the co-authorship network connecting the top 25 collaborators of Minjun Du. A scholar is included among the top collaborators of Minjun Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjun Du. Minjun Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Meng, Xiangzhi, et al.. (2024). FSTL3 is associated with prognosis and immune cell infiltration in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 150(1). 17–17. 5 indexed citations
3.
4.
Du, Minjun, et al.. (2024). A risk score based on polyamine metabolism and chemotherapy‐related genes predicts prognosis and immune cells infiltration of lung adenocarcinoma. Journal of Cellular and Molecular Medicine. 28(12). e18387–e18387. 1 indexed citations
5.
Du, Minjun, et al.. (2023). A tricarboxylic acid cycle-based machine learning model to select effective drug targets for the treatment of esophageal squamous cell carcinoma. Frontiers in Pharmacology. 14. 1195195–1195195. 6 indexed citations
6.
Lei, Yangyang, Mei Liang, Minjun Du, et al.. (2022). GBE1 Is an Independent Prognostic Marker and Associated With CD163+ Tumor-Associated Macrophage Infiltration in Lung Adenocarcinoma. Frontiers in Oncology. 11. 781344–781344. 7 indexed citations
7.
Wang, Ling, et al.. (2022). Plasm Metabolomics Study in Pulmonary Metastatic Carcinoma. Journal of Oncology. 2022. 1–14. 8 indexed citations
8.
Du, Minjun, Zixu Liu, Xingkai Li, et al.. (2021). Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma. Frontiers in Oncology. 11. 693353–693353. 9 indexed citations
9.
Lei, Yangyang, Minjun Du, Mei Liang, et al.. (2021). The increased expression and aberrant methylation of SHC1 in non–small cell lung cancer: Integrative analysis of clinical and bioinformatics databases. Journal of Cellular and Molecular Medicine. 25(14). 7039–7051. 9 indexed citations
10.
Li, Xingkai, Fang Lv, Li Fang, et al.. (2020). LINC01089 Inhibits Tumorigenesis and Epithelial–Mesenchymal Transition of Non-small Cell Lung Cancer via the miR-27a/SFRP1/Wnt/β-catenin Axis. Frontiers in Oncology. 10. 532581–532581. 21 indexed citations
11.
Li, Xingkai, Fang Lv, Fang Li, et al.. (2020). <p>Long Noncoding RNA H19 Facilitates Small Cell Lung Cancer Tumorigenesis Through miR-140-5p/FGF9 Axis</p>. OncoTargets and Therapy. Volume 13. 3525–3534. 18 indexed citations
12.
Liu, Terry Z., et al.. (2020). Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer. Surgery Today. 50(8). 881–888. 4 indexed citations
13.
Liu, Terry Z., et al.. (2019). Imaging Features and Clinical Decision Analysis of 110 Cases of Intrapulmonary Lymph Nodes. The Thoracic and Cardiovascular Surgeon. 68(7). 652–658. 1 indexed citations
14.
Wang, Bing, et al.. (2017). Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis. Open Medicine. 12(1). 86–91. 3 indexed citations
15.
Wang, Bing, et al.. (2017). MiR-107 inhibits proliferation of lung cancer cells through regulating TP53 regulated inhibitor of apoptosis 1 (TRIAP1). Open Life Sciences. 12(1). 200–205. 3 indexed citations
16.
Wang, Bing, Fang Lv, Liang Zhao, Minjun Du, & Shugeng Gao. (2017). [Video-assisted Thoracoscope versus Video-assisted Mini-thoracotomy for Non-small Cell Lung Cancer: A Meta-analysis].. SHILAP Revista de lepidopterología. 20(5). 303–311.
17.
Du, Minjun, Yanjiao Zhang, Yousheng Mao, et al.. (2016). MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochemical and Biophysical Research Communications. 482(4). 582–589. 161 indexed citations
18.
Gao, Yushun, Qi Xue, Dali Wang, et al.. (2015). miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.. PubMed. 7(11). 2519–26. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingting Ying Breakdown of academic impact, for papers by Yi Miao Breakdown of academic impact, for papers by Zhi‐Man Zhu Breakdown of academic impact, for papers by Senxu Lu Breakdown of academic impact, for papers by Lingxing Zeng Breakdown of academic impact, for papers by Lisha Zhuang Breakdown of academic impact, for papers by Naichun Zhou Breakdown of academic impact, for papers by Chengzhou Lv Breakdown of academic impact, for papers by Bingrui Yan Breakdown of academic impact, for papers by Junge Deng
Rankless by CCL
2026